查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561443

2024-2032 年按类型、医疗状况、技术、最终用户和地区分類的运营商筛选市场报告

Carrier Screening Market Report by Type, Medical Condition, Technology, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球带因者筛检市场IMARC Group达到 19 亿美元。全球市场的主要驱动因素包括遗传技术的不断进步、人们对早期遗传性疾病检测的认识和需求的提高、政府的支持性倡议、遗传性疾病发病率的上升、新生儿筛检计画的扩大以及个性化医疗的日益采用。

营运商筛检市场分析：

  • 主要市场驱动力：遗传技术的进步、对遗传性疾病认识的提高、政府支持、遗传性疾病盛行率的增加以及新生儿筛检计画的扩大正在推动全球市场的发展。
  • 主要市场趋势：携带者筛检市场的主要趋势包括扩大携带者筛检的主导地位、DNA定序技术的主导作用、医院和诊所的主导地位、北美最大的市场份额以及肺部疾病在医疗状况中的突出地位。
  • 地理趋势：北美由于先进的医疗基础设施和高认知度而处于领先地位。欧洲紧随其后，越来越多地采用基因检测。在医疗保健投资和意识不断提高的推动下，亚太地区出现了快速成长。
  • 竞争格局：带因者筛检产业的一些主要市场参与者包括 Myriad Genetics、Invitae、Natera、Quest Diagnostics、Laboratory Corporation of America Holdings (LabCorp) 和 Illumina。这些公司凭藉先进的技术和广泛的服务而处于领先地位。
  • 挑战与机会：挑战包括监管复杂性和道德考量。机会在于技术进步、扩大市场范围以及加强与医疗保健提供者的合作以提高服务的可及性和有效性。

营运商筛检市场趋势：

基因技术的不断进步

基因技术的新兴创新正在支持载体筛检市场的成长。分子诊断测试的进步导致了更新更好的方法的发展，例如用于同时筛检多种遗传性疾病的下一代定序（NGS）。这些技术的发展和改进不仅有助于降低基因检测的成本，也有助于大众获得基因检测。因此，医疗保健提供者能够提供改进和准确的携带者筛检，随着遗传性疾病知识的不断发展以及筛检仪器的增强，有助于携带者筛检市场的进步。

意识和需求不断提高

由于早期遗传性疾病检测的需求不断增长，带因者筛检市场前景乐观。随着越来越多的个人和夫妇希望免受此类遗传性疾病的影响，携带者筛检测试也不断增加。卫生机构增加的教育计划以及将遗传咨询纳入标准医疗服务中正在支持市场的成长。此外，随着人们对遗传疾病的认识不断增强，加上疾病的早期发现和预防的转变，人们开始选择带因者筛检。随着及时检测提高了生活品质和生殖选择，这种趋势预计未来将持续，并保持市场的上升趋势。

政府角色和报销

携带者筛选产业受到政府政策和行动以及报销政策积极趋势的推动。卫生和政府政策制定者开始认识到产前筛检对于预防遗传性疾病的传播至关重要。因此，有措施将携带者筛检纳入国家医疗保健计划和保险政策框架内提供的强制性服务清单中。这些测试越来越受欢迎，因为报销政策使它们变得更便宜，因此更容易为客户所接受。此外，政府资金也有所增加，用于支持基因筛检技术的研究和开发，从而促进该产业的扩张。这些支持措施很有价值，因为它们有助于促进携带者筛检的增加，从而增强该行业的实力。

营运商筛选市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、医疗状况、技术和最终用户对市场进行了分类。

按类型划分：

  • 扩大携带者筛检
    • 客製化面板测试
    • 预先设计的面板测试
  • 针对性疾病带因者筛检

扩大的携带者筛检占据了大部分市场份额

该报告根据类型提供了详细的市场细分和分析。这包括扩大携带者筛检（客製化的小组测试和预先设计的小组测试）和有针对性的疾病携带者筛检。根据该报告，扩大携带者筛检是最大的部分。

扩大的携带者筛检提供了有关包括罕见疾病在内的各种疾病的更多信息，因此它是医疗保健提供者和患者的首选选择。它能够在一次测试中提供个人多种疾病携带者状态的综合结果，这推动了它的流行。它还有助于提供更好的诊断准确性，并有助于在计划生育和管理方面做出更好的决策。人们对准父母双方遗传健康的日益关注，以及新的、更先进的携带者检测方法的可及性，促进了更广泛的携带者筛检的持续普及，从而巩固了市场的领先地位。

按医疗状况划分：

  • 肺部疾病
  • 血液学状况
  • 神经系统疾病
  • 其他的

肺部疾病占据产业最大份额

报告还根据医疗状况对市场进行了详细的细分和分析。这包括肺部疾病、血液疾病、神经系统疾病等。报告称，肺部疾病占据了最大的市场份额。

肺部疾病代表了市场上最大的细分市场。包括囊性纤维化在内的疾病更为普遍，对健康造成严重影响，因此，应儘早、正确地进行筛检以控制后果。目前关于肺部疾病带原者筛检重要性的观点也值得考虑，因为及时识别潜在带原者并制定有效的治疗计划最终可以挽救患者的生命并提高他们的生活品质。可靠的筛检测试和对带因者领域研究的关注也在肺部疾病筛检主导的重要市场份额中发挥关键作用。对疾病预防和基因检测的关注也更广泛地增强了肺部疾病在该领域的中心地位。

按技术划分：

  • DNA定序
  • 聚合酶炼式反应
  • 微阵列
  • 其他的

DNA 定序代表了领先的细分市场

该报告基于该技术对市场进行了详细的细分和分析。这包括 DNA 定序、聚合酶炼式反应、微阵列等。报告称，DNA 定序是最大的部分。

透过 DNA 定序进行的携带者测试已被确定为市场中最主要的技术领域。这种增强的科学透过寻找可能决定此类遗传性疾病携带者状态的可能突变来帮助表征 DNA 材料。 DNA 定序技术的进步，例如高精度、序列资料生成效率高以及与其他方法相比成本降低等，使 DNA 定序成为首选的载体筛选技术。在遗传性疾病和疾病的情况下需要及早做出规定，这使得它有助于提供充分和准确的遗传资讯。随着定序技术的进步，基因分析中的载体筛选已经更加深入和广泛。

按最终用户划分：

  • 医院和诊所
  • 参考实验室
  • 其他的

医院和诊所在市场上表现出明显的主导地位

报告还提供了基于最终用户的详细市场细分和分析。这包括医院和诊所、参考实验室等。报告显示，医院和诊所占据了最大的市场。

根据带因者筛检市场趋势，医院和诊所成为最终用户的主导部分。这些是客户可以获得基因诊断的典型医疗设施。携带者测试涉及进行详尽的筛检测试和随后的咨询——医院和诊所有足够的能力透过其必要的基础设施、人员和设备来处理这一方面。这些服务被转化为使携带者筛检广泛普及，因为提供产前和孕前护理的机构都纳入了这项服务。此外，对医院和诊所的信任和信誉促使更多的人选择带因者筛检。随着基因检测在这些医疗机构中的现有扩展，主要参与者背后的市场基本面得到加强，这对携带者筛检服务的推广做出了积极贡献。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美市场领先，占据最大的营运商筛选市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是携带者筛检的最大区域市场。

由于更好的医疗设施、提高的意识水平以及支持进行此类基因测试的政府法律，北美占据了最大的市场份额。所有主要基因检测公司的可用性以及正在进行的遗传学研究也对该领域处于领先地位发挥了作用。北美地区对于疾病的预防相对较重视，带因者筛检的使用率也比较高。此外，获得理想的基因测试保险范围也为市场创造了额外的需求。消费者对携带者筛检的兴趣不断增加，特别是在个人化用药和早期疾病诊断方面，北美先进的医疗保健产业及其积极的基因筛检方法将继续促进其在全球市场的成长。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。载体筛检产业的一些主要市场参与者包括

  • 富金遗传学
  • 基因基因有限公司 (MyDNA)
  • 照明公司
  • 英维泰公司
  • 医学基因组实验室有限公司
  • 无数遗传学公司
  • 纳特拉公司
  • OPKO 健康公司
  • 探索诊断
  • 塞玛4
  • 赛默飞世尔科技公司

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

职业筛选公司正在迅速提高其技术进步和市场覆盖范围。 Myriad Genetics、Invitae、Natera 和其他各种基因检测公司也投入资源来提高灵敏度并扩大可透过基因检测检测的疾病清单。他们还与医疗保健服务提供者和设施签订各种从属关係和服务协议，以使其服务提供组合多样化。这些参与者正在寻求采用 NGS 等革命性技术，使他们的携带者筛检更加准确和包容。此外，他们还将加强宣传力度，促进民众使用带因者筛检。市场的关键策略是透过提高价格竞争力来提高可及性以及扩大领土，使某些关键参与者加强其地位并促进市场的发展。

营运商筛检市场新闻：

  • 2023 年 9 月 13 日，Devyser 和 Thermo Fisher Scientific 合作推广实验室服务，以推进药物研究。目标是利用 Devyser 在其 CLIA 认证实验室中的独特检测来支持他们的开发项目。
  • 2023 年 7 月 11 日，Quest Diagnostics 推出了首个以消费者为中心的基因测试「Genetic Insights」。这项新服务帮助个人了解他们患遗传性疾病的风险。该服务还包括个人化的健康报告和遗传咨询。
  • 2023 年 3 月 2 日，Illumina Inc. 和 Myriad Genetics Inc. 宣布扩大策略伙伴关係，以扩大肿瘤同源重组缺陷 (HRD) 检测的可及性和可用性。

本报告回答的关键问题：

  • 迄今为止，全球带因者筛检市场表现如何，未来几年将如何表现？
  • 全球带因者筛检市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球携带者筛检市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的携带者筛检市场？
  • 依类型划分市场是怎么样的？
  • 携带者筛检市场中哪种类型最有吸引力？
  • 基于医疗状况的市场区隔是什么？
  • 携带者筛检市场中最具吸引力的医疗状况是什么？
  • 什么是基于技术的市场分割？
  • 载体筛检市场中哪一项技术最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 载体筛选市场中哪一个对最终用户最具吸引力？
  • 市场竞争结构如何？
  • 全球携带者筛检市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球带因者筛检市场表现如何，未来几年将如何表现？
  • 全球带因者筛检市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球携带者筛检市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的携带者筛检市场？
  • 依类型划分市场是怎么样的？
  • 携带者筛检市场中哪种类型最有吸引力？
  • 基于医疗状况的市场区隔是什么？
  • 携带者筛检市场中最具吸引力的医疗状况是什么？
  • 什么是基于技术的市场分割？
  • 载体筛检市场中哪一项技术最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 载体筛选市场中哪一个对最终用户最具吸引力？
  • 市场竞争结构如何？
  • 全球携带者筛检市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球营运商筛选市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 扩大携带者筛检
    • 市场趋势
    • 关键环节
      • 客製化面板测试
      • 预先设计的面板测试
    • 市场预测
  • 针对性疾病带因者筛检
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依医疗状况

  • 肺部疾病
    • 市场趋势
    • 市场预测
  • 血液学状况
    • 市场趋势
    • 市场预测
  • 神经系统疾病
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • DNA定序
    • 市场趋势
    • 市场预测
  • 聚合酶炼式反应
    • 市场趋势
    • 市场预测
  • 微阵列
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 参考实验室
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Fulgent Genetics
    • Gene：By Gene Ltd. (MyDNA)
    • Illumina Inc.
    • Invitae Corporation
    • MedGenome Labs Ltd.
    • Myriad Genetics Inc.
    • Natera Inc.
    • OPKO Health Inc.
    • Quest Diagnostics
    • Sema4
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4417

The global carrier screening market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The global market is majorly driven by continual advancements in genetic technology, increasing awareness and demand for early genetic disorder detection, supportive government initiatives, rising incidence of genetic disorders, expansion of newborn screening programs, and the growing adoption of personalized medicine.

Carrier Screening Market Analysis:

  • Major Market Drivers: Advancements in genetic technology, rising awareness of genetic disorders, government support, increasing prevalence of genetic conditions, and expansion of newborn screening programs are driving the global market.
  • Key Market Trends: Key trends in the carrier screening market include the predominance of expanded carrier screening, the leading role of DNA sequencing technology, the dominance of hospitals and clinics, North America's largest market share, and the prominence of pulmonary conditions in medical condition-focused screening.
  • Geographical Trends: North America leads due to advanced healthcare infrastructure and high awareness. Europe follows with increasing adoption of genetic testing. Asia-Pacific shows rapid growth driven by healthcare investments and rising awareness.
  • Competitive Landscape: Some major market players in the carrier screening industry include Myriad Genetics, Invitae, Natera, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Illumina. These companies lead with advanced technologies and extensive service offerings.
  • Challenges and Opportunities: Challenges include regulatory complexities and ethical considerations. Opportunities lie in technological advancements, expanding market reach, and increasing collaborations with healthcare providers to enhance service accessibility and efficacy.

Carrier Screening Market Trends:

Continual advancements in genetic technology

Emerging innovations in genetic technology are supporting the carrier screening market growth. Advancements in molecular diagnostic testing have led to the development of newer and better methods, such as the next-generation sequencing (NGS) for screening several genetic disorders at once. These technological developments and improvements have not only contributed to the lowering of the cost of genetic testing, but also to its accessibility to the public. Healthcare providers are thus able to provide improved and accurate carrier screening, with numerous developments in the knowledge of genetic disorders to grow along with the enhancements in screening instruments contributing to the progress of the market for carrier screening.

Rising awareness and demand

The carrier screening market outlook is positive due to the rising demand for early genetic disorders detection. Carrier screening tests are also on the rise as more individuals and couples want to be protected from such inherited conditions. Increased education programs by health bodies and incorporating genetic counseling into standard healthcare services are supporting the growth of the market. Furthermore, as there is increasing awareness of genetic diseases, coupled with the shift for early detection of diseases and prevention, individuals are opting for carrier screening. This trend is expected to continue in the future, and maintain the market's upward trend, as timely detection enhances the quality of life and reproductive choices.

Government roles and reimbursements

The carrier screening industry is propelled by governmental policies and actions, as well as a positive trend in reimbursement policies. Health and government policy makers are beginning to understand that pre-natal screenings are essential in preventing the spread of genetic disorders. Consequently, there are measures to introduce carrier screening into the list of mandatory services provided within the framework of state health care programs and insurance policies. These tests are growing popular as reimbursement policies have made them cheaper and thus more accessible to clients. Also, there is an increase in government funding that supports research and development in genetic screening technologies and therefore the expansion occurring in the industry. Such supportive measures are valuable as they help to facilitate the increased use of carrier screening, which in turn strengthens the industry.

Carrier Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, medical condition, technology and end user.

Breakup by Type:

  • Expanded Carrier Screening
    • Customized Panel Testing
    • Predesigned Panel Testing
  • Targeted Disease Carrier Screening

Expanded carrier screening accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes expanded carrier screening (customized panel testing and predesigned panel testing) and targeted disease carrier screening. According to the report, expanded carrier screening represented the largest segment.

Expanded carrier screening provides added information as to various conditions including rare ones, due to which it is a preferred option both by healthcare providers as well as the patients. Its ability to offer comprehensive results of an individual's carrier status for multiple disorders in a single test has propelled its popularity. It also helps to provide better diagnostic accuracy and assists in making better decisions as to family planning and management. The increasing focus on the genetic health of both parents-to-be and the accessibility of new and more sophisticated carrier detection methods add to the continued popularity of more extensive carrier screening, which cements the leading position of the market.

Breakup by Medical Condition:

  • Pulmonary Conditions
  • Hematological Conditions
  • Neurological Conditions
  • Others

Pulmonary conditions holds the largest share of the industry

A detailed breakup and analysis of the market based on the medical condition have also been provided in the report. This includes pulmonary conditions, hematological conditions, neurological conditions, and others. According to the report, pulmonary conditions accounted for the largest market share.

Pulmonary conditions represents the largest market segment in the market. Diseases, including cystic fibrosis are more prevalent with serious effects on health, therefore, screening should be done early and correctly to contain the consequences. Current opinions regarding the importance of carrier screening for pulmonary conditions are also worth considering, as the timely identification of the potential carriers and the development of an effective treatment plan can ultimately save the patient's life and improve their quality of living. Reliable screening tests and focus on the research aspect in the carrier field also play a key role in significant market share being dominated by the pulmonary conditions screening. The focus on disease prevention and genetic testing also bolster the centrality of pulmonary disorders in the sector more widely.

Breakup by Technology:

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

DNA sequencing represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes DNA sequencing, polymerase chain reaction, microarrays, and others. According to the report, DNA sequencing represented the largest segment.

Carrier testing by DNA sequencing has been identified to be the most dominant segment within the market by technology. This enhanced science helps in the characterization of DNA materials by finding possible mutations that may determine the carrier status of such inherited ailments. Advancements in DNA sequencing such as high precision, efficiency in generating sequence data and the reduced cost compared to other methods have made DNA sequencing the carrier screening technique of choice. The need to make early provisions in cases of genetic disorders and diseases makes it instrumental in offering adequate and accurate genetic information. With the advancement in sequencing technology, carrier screening has been through more depth and spectrum in genetic analysis.

Breakup by End User:

  • Hospitals and Clinics
  • Reference Laboratories
  • Others

Hospitals and clinics exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, reference laboratories, and others. According to the report, hospitals and clinics accounted for the largest market share.

As per the carrier screening market trends, hospitals and clinics emerged as the leading segment for end user. These are the typical medical facilities where clients can get access to genetic diagnostics. Carrier testing involves the performance of exhaustive screening tests and subsequent counseling- an aspect that hospitals and clinics are well equipped to handle through their necessary infrastructure, personnel, and equipment. These services are translated to make access to carrier screening widespread since the facilities offering prenatal and preconception care incorporate this service. Also, the trust and credibility that are attributed to hospitals and clinics push more individuals into selecting carrier screening. With the existing expansion of genetic testing across these healthcare institutions, the market fundamentals are strengthened behind the key players, which positively contributes to the promotion of carrier screening services.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest carrier screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for carrier screening.

North America is the largest market share due to better healthcare facilities, increased awareness levels, and supportive government laws to carry out such genetic tests. The availability of all major genetic testing companies and the on-going research regarding genetics also play a role in placing the area at the top. In North America, there is a relatively greater focus on the prevention of diseases, and usage of carrier screenings is also relatively high. Moreover, the access to desirable insurance coverage for genetic tests creates additional demand for the market. The increased consumer interest in carrier screenings, especially in personalized medication and early disease diagnosis, and North America's advanced healthcare industry as well as its active approach to genetic screening will continue to foster its growth in the global market.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the carrier screening industry include

  • Fulgent Genetics
  • Gene By Gene Ltd. (MyDNA)
  • Illumina Inc.
  • Invitae Corporation
  • MedGenome Labs Ltd.
  • Myriad Genetics Inc.
  • Natera Inc.
  • OPKO Health Inc.
  • Quest Diagnostics
  • Sema4
  • Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Career screening companies are rapidly increasing their technological advancement and market coverage. Myriad Genetics, Invitae, and Natera and various other genetic testing companies are also committing resources to the improvement of sensitivity and the expanding the list of diseases amenable to detection through genetic testing. They are also entering into various affiliation and service agreements with healthcare service providers and facilities to diversify their service delivery portfolios. These players are looking to adopt revolutionary technologies such as NGS that will enable them to make their carrier screening more accurate and inclusive. Also, they are to increase awareness efforts in promoting the use of carrier screening among the populace. Key strategies of the market identified as the improvement of accessibility by making prices more competitive, as well as the expansion of the territory, make certain critical players strengthen their positions and promote the development of the market.

Carrier Screening Market News:

  • On 13th September 2023, Devyser and Thermo Fisher Scientific collaborated to promote laboratory services to advance pharmaceutical research. The goal was to support their development projects utilizing Devyser's unique assays in its CLIA-certified laboratory.
  • On 11th July 2023, Quest diagnostics launched its first consumer-focused genetic test, genetic insights. The new service help individuals to understand their risk of developing inheritable medical conditions. The service also includes personalized health reports and access to genetic counselling.
  • On 2nd March 2023, Illumina Inc. and Myriad Genetics Inc. announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous recombination deficiency (HRD) testing.

Key Questions Answered in This Report:

  • How has the global carrier screening market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global carrier screening market?
  • What is the impact of each driver, restraint, and opportunity on the global carrier screening market?
  • What are the key regional markets?
  • Which countries represent the most attractive carrier screening market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the carrier screening market?
  • What is the breakup of the market based on the medical condition?
  • Which is the most attractive medical condition in the carrier screening market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the carrier screening market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the carrier screening market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global carrier screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Carrier Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Expanded Carrier Screening
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Customized Panel Testing
      • 6.1.2.2 Predesigned Panel Testing
    • 6.1.3 Market Forecast
  • 6.2 Targeted Disease Carrier Screening
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Medical Condition

  • 7.1 Pulmonary Conditions
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hematological Conditions
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Conditions
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 DNA Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Fulgent Genetics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Gene By Gene Ltd. (MyDNA)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Illumina Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Invitae Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 MedGenome Labs Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Myriad Genetics Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 OPKO Health Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Quest Diagnostics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sema4
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Carrier Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2023
  • Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Carrier Screening Industry: SWOT Analysis
  • Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
  • Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Carrier Screening Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Carrier Screening Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Carrier Screening Market Forecast: Breakup by Medical Condition (in Million US$), 2024-2032
  • Table 4: Global: Carrier Screening Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Carrier Screening Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Carrier Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Carrier Screening Market: Competitive Structure
  • Table 8: Global: Carrier Screening Market: Key Players